Physician profile
Nitin Krishnaji Kulkarni
NPI 1770807612
$2,794.01
in general payments reported to CMS, 2019-2025
9 companies · $1,130 in 2025
The $1,130 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2021: $62.64 · 2022: $167 · 2023: $541 · 2024: $508 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,178.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,142.51 | 2022-2025 | Micra, Affera Mapping System, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $465.60 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Merlin@Home |
| Boston Scientific Corporation | $370.75 | 2019 | |
| Biosense Webster, INC. | $305.77 | 2021-2024 | Carto 3 |
| Cordis US Corp. | $252.50 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $138.64 | 2023-2025 | Camzyos |
| Abiomed | $52.67 | 2024 | |
| Pfizer INC. | $47.81 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Kulkarni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.